OMCL - Omnicell Health Price-to-Projected Revenue Ratio

omnicell.com - graphic logo of issuer OMCL

Omnicell, Inc. (OMCL) is currently focusing on internal updates and organic growth following a period of active mergers. Competent management aims to restore sales momentum, as confirmed by the forward P/S trend on GURU.Markets, where the 0.60 mark records this metric. Operational efficiency is maintained by outsourcing equipment production and services to third-party contractors.

OMCL (omnicell.com) Forward Price to Sales history from 07/04/2022 to 11/13/2026

Omnicell Health - analytical breakdowns and key metrics (OMCL)

- market price and analyst price targets:
- market capitalization statistics:
Analysis of all company metrics:Omnicell (OMCL)
Original product of Omnicell Health

For Omnicell, Inc. (OMCL), business valuation relative to future revenue streams is critical due to its dependence on government procurement cycles. The forward P/S multiple compares current market capitalization with expected sales volume. This chart reflects the market's reassessment of risks associated with delays in hospital system modernization and the implementation of cloud services. A decline in this metric may indicate either an undervalued asset or a systemic slump in demand.

Analysis of competing companies

Price-to-Projected Revenue Ratio Veeva VEEV|Doximity Inc - Price-to-Projected Revenue Ratio|HQY - Price-to-Projected Revenue Ratio|WAY: Price-to-Projected Revenue Ratio|CRVL (CorVel Corporation) - Forward Price-to-Revenue Multiple|priviahealth.com - Forward Price to Sales|HURN (Huron) - Forward P/S Multiple|Certara Inc (CERT) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio GoodRx Corp (GDRX)|Schrodinger Corp - Market Cap to Projected Revenue|Forward P/S Multiple PHR (Phreesia, Inc.)|OMDA - Forward Price-to-Revenue Multiple|EVH: Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio HealthStream Inc HSTM|Definitive Healthcare Inc. (DH) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Consensus Corp (CCSI)|Price-to-Projected Revenue Ratio Agilon Health|Forward Price-to-Revenue Multiple absci.com (ABSI)|Forward P/S Multiple SY|Forward Price-to-Revenue Multiple NRC Health NRC|Price-to-Projected Revenue Ratio Spok Corp SPOK|OptimizeRx Inc. - Price-to-Projected Revenue Ratio|TruBridge, Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio simulations-plus.com SLP|SOPH (sophiagenetics.com) - Forward Price-to-Revenue Multiple|HCAT: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple CCLD|RSSS: Forward Price to Sales|Price-to-Projected Revenue Ratio DLH Holdings Corp. (DLHC)|Forward Price-to-Revenue Multiple onemednet.com ONMD|Forward P/S Multiple SCNX (Scienture)|Healthcare Triangle Inc (HCTI) - Market Cap to Future Revenue Ratio|iSpecimen Corp - Forward P/S Multiple|BFRG (Bullfrog AI Holdings) - Market Cap to Projected Revenue|SCWorx Corp. (WORX) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio msprecovery.com (MSPR)|Price-to-Projected Revenue Ratio iCoreConnect, Inc.|Forward Price-to-Revenue Multiple TRxADE HEALTH Inc (MEDS)|Price-to-Projected Revenue Ratio Orgenesis Corp (ORGS)|r1rcm.com - Market Cap to Projected Revenue|Forward P/S Multiple SHCR (Sharecare, Inc.)|Market Cap to Expected Sales Ratio streamlinehealth.net (STRM)|Syra Health - Forward P/S Multiple|Apollo Medical Holdings (AMEH) - Forward Price-to-Revenue Multiple|MODN: Forward P/S Multiple|Market Cap to Future Revenue Ratio NextGen Healthcare Corp (NXGN)